Global Artificial Blood Vessel Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global FIB-SEM System market size is predicted to grow from US$ 644 million in 2025 to US$ 910 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The FIB-SEM system is an electron microscope system that integrates focused electron beams and scanning ion beams. Focused ion beams can be used for micro processing of samples, scanning electron beams can be used for micro imaging and 'two-dimensional' characterization analysis of sample surface morphology, and real-time observation of the FIB processing process. Therefore, the FIB-SEM system can achieve fixed-point etching, deposition, cross-sectional cutting, TEM electron microscopy sample preparation, and micro/nano device preparation of samples Circuit repair, 3D structural characterization, etc.
Global key players of FIB-SEM System include Thermo Fisher Scientific Hitachi and Zeiss, etc. The top three players hold a share over 85%. Japan is the largest market. In terms of product type, Ga Ion Source is the largest segment, occupied for a share of 95%, and in terms of application, Material Science has a share about 40 percent.
Analysis of FIB-SEM system market drivers
1. Demand for semiconductor technology iteration
Advanced process node promotion:
3nm/2nm chip process requires atomic-level defect detection, and FIB-SEM supports nanoscale circuit editing and material composition analysis (such as EDS/EBSD integration) to help improve yield.
3D packaging technology (such as Chiplet) relies on FIB-SEM for through-silicon via (TSV) cross-sectional analysis and interface defect positioning.
Semiconductor material innovation:
The microstructure research of third-generation semiconductors (GaN, SiC) and two-dimensional materials (graphene) requires FIB-SEM to achieve atomic-level resolution imaging (<0.5nm).
2. Biomedical and life science research
Tissue engineering and drug delivery:
FIB-SEM supports cell-material interface imaging, analyzes the distribution of nanoparticles in the body, and accelerates targeted drug development.
Brain neuroscience: 3D reconstruction of the whole brain neural network is achieved through volume electron microscopy (SBEM), promoting the study of the mechanism of neurodegenerative diseases.
Implantable medical devices:
Analysis of nanoscale surface morphology of biocompatible materials (such as degradable stents) to optimize device design.
3. Breakthroughs in materials science
Research and development of new energy materials:
Study on the growth mechanism of lithium dendrites in solid-state batteries requires FIB-SEM combined with low-temperature in-situ electron microscopy technology.
Analysis of hydrogen embrittlement: Observation of metal microscopic crack propagation in transmission electron microscope samples prepared by FIB.
Design of nanocomposite materials:
FIB-SEM supports 3D structural characterization of multimodal materials (such as graphene/metal composites) to help optimize performance.
4. Industry 4.0 and smart manufacturing
Micro-nano manufacturing upgrade:
The complex structure processing of MEMS sensors (such as inertial measurement units) relies on the ion beam direct writing technology of FIB-SEM.
Nanoscale circuit repair of flexible electronics (such as foldable screens) drives the growth of equipment demand.
Intelligent quality control:
AI integrated FIB-SEM system realizes automated defect detection (such as wafer surface particle analysis) to improve production line efficiency.
5. Academic and policy support
Research funding:
Global nanotechnology R&D investment increased by 8% annually (NSF data), and universities/national laboratories purchased FIB-SEM for cutting-edge exploration.
China's '14th Five-Year Plan' focuses on supporting the localization of electron microscopes, giving rise to local equipment demand.
Open source science trends:
FIB-SEM data sharing platforms (such as EMPIAR) promote interdisciplinary cooperation and accelerate technology popularization.
6. Technology integration and innovation
Multimodal combined technology:
FIB-SEM is integrated with Raman spectroscopy/AFM to achieve morphology-composition-mechanics multi-attribute correlation analysis.
In-situ electrical testing: Directly measure carrier transport characteristics on FIB-prepared nanostructures.
AI-assisted analysis:
Deep learning algorithms increase FIB-SEM imaging speed by 3-5 times and reduce the operating threshold.
Market growth forecast and competition focus.
Decisive factors:
Resolution and processing accuracy: Breakthrough to sub-nanometer level (<0.3nm) to support quantum material research.
Automation and data ecology: Develop AI-driven full-process solutions (such as sample preparation-imaging-analysis integration).
Summary: The three core driving forces of semiconductor technology generational evolution, biomedical interdisciplinary integration, and material science paradigm innovation, coupled with policy support and AI technology empowerment, promote FIB-SEM from a scientific research tool to an industrial standard. Chinese companies need to break through the bottlenecks of ion source stability and software algorithms to seize the high-end market.
LP Information, Inc. (LPI) ' newest research report, the “FIB-SEM System Industry Forecast” looks at past sales and reviews total world FIB-SEM System sales in 2024, providing a comprehensive analysis by region and market sector of projected FIB-SEM System sales for 2025 through 2031. With FIB-SEM System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIB-SEM System industry.
This Insight Report provides a comprehensive analysis of the global FIB-SEM System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIB-SEM System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global FIB-SEM System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIB-SEM System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIB-SEM System.
This report presents a comprehensive overview, market shares, and growth opportunities of FIB-SEM System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global FIB-SEM System market?
What factors are driving FIB-SEM System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIB-SEM System market opportunities vary by end market size?
How does FIB-SEM System break out by Type, by Application?
The global FIB-SEM System market size is predicted to grow from US$ 644 million in 2025 to US$ 910 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The FIB-SEM system is an electron microscope system that integrates focused electron beams and scanning ion beams. Focused ion beams can be used for micro processing of samples, scanning electron beams can be used for micro imaging and 'two-dimensional' characterization analysis of sample surface morphology, and real-time observation of the FIB processing process. Therefore, the FIB-SEM system can achieve fixed-point etching, deposition, cross-sectional cutting, TEM electron microscopy sample preparation, and micro/nano device preparation of samples Circuit repair, 3D structural characterization, etc.
Global key players of FIB-SEM System include Thermo Fisher Scientific Hitachi and Zeiss, etc. The top three players hold a share over 85%. Japan is the largest market. In terms of product type, Ga Ion Source is the largest segment, occupied for a share of 95%, and in terms of application, Material Science has a share about 40 percent.
Analysis of FIB-SEM system market drivers
1. Demand for semiconductor technology iteration
Advanced process node promotion:
3nm/2nm chip process requires atomic-level defect detection, and FIB-SEM supports nanoscale circuit editing and material composition analysis (such as EDS/EBSD integration) to help improve yield.
3D packaging technology (such as Chiplet) relies on FIB-SEM for through-silicon via (TSV) cross-sectional analysis and interface defect positioning.
Semiconductor material innovation:
The microstructure research of third-generation semiconductors (GaN, SiC) and two-dimensional materials (graphene) requires FIB-SEM to achieve atomic-level resolution imaging (<0.5nm).
2. Biomedical and life science research
Tissue engineering and drug delivery:
FIB-SEM supports cell-material interface imaging, analyzes the distribution of nanoparticles in the body, and accelerates targeted drug development.
Brain neuroscience: 3D reconstruction of the whole brain neural network is achieved through volume electron microscopy (SBEM), promoting the study of the mechanism of neurodegenerative diseases.
Implantable medical devices:
Analysis of nanoscale surface morphology of biocompatible materials (such as degradable stents) to optimize device design.
3. Breakthroughs in materials science
Research and development of new energy materials:
Study on the growth mechanism of lithium dendrites in solid-state batteries requires FIB-SEM combined with low-temperature in-situ electron microscopy technology.
Analysis of hydrogen embrittlement: Observation of metal microscopic crack propagation in transmission electron microscope samples prepared by FIB.
Design of nanocomposite materials:
FIB-SEM supports 3D structural characterization of multimodal materials (such as graphene/metal composites) to help optimize performance.
4. Industry 4.0 and smart manufacturing
Micro-nano manufacturing upgrade:
The complex structure processing of MEMS sensors (such as inertial measurement units) relies on the ion beam direct writing technology of FIB-SEM.
Nanoscale circuit repair of flexible electronics (such as foldable screens) drives the growth of equipment demand.
Intelligent quality control:
AI integrated FIB-SEM system realizes automated defect detection (such as wafer surface particle analysis) to improve production line efficiency.
5. Academic and policy support
Research funding:
Global nanotechnology R&D investment increased by 8% annually (NSF data), and universities/national laboratories purchased FIB-SEM for cutting-edge exploration.
China's '14th Five-Year Plan' focuses on supporting the localization of electron microscopes, giving rise to local equipment demand.
Open source science trends:
FIB-SEM data sharing platforms (such as EMPIAR) promote interdisciplinary cooperation and accelerate technology popularization.
6. Technology integration and innovation
Multimodal combined technology:
FIB-SEM is integrated with Raman spectroscopy/AFM to achieve morphology-composition-mechanics multi-attribute correlation analysis.
In-situ electrical testing: Directly measure carrier transport characteristics on FIB-prepared nanostructures.
AI-assisted analysis:
Deep learning algorithms increase FIB-SEM imaging speed by 3-5 times and reduce the operating threshold.
Market growth forecast and competition focus.
Decisive factors:
Resolution and processing accuracy: Breakthrough to sub-nanometer level (<0.3nm) to support quantum material research.
Automation and data ecology: Develop AI-driven full-process solutions (such as sample preparation-imaging-analysis integration).
Summary: The three core driving forces of semiconductor technology generational evolution, biomedical interdisciplinary integration, and material science paradigm innovation, coupled with policy support and AI technology empowerment, promote FIB-SEM from a scientific research tool to an industrial standard. Chinese companies need to break through the bottlenecks of ion source stability and software algorithms to seize the high-end market.
LP Information, Inc. (LPI) ' newest research report, the “FIB-SEM System Industry Forecast” looks at past sales and reviews total world FIB-SEM System sales in 2024, providing a comprehensive analysis by region and market sector of projected FIB-SEM System sales for 2025 through 2031. With FIB-SEM System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIB-SEM System industry.
This Insight Report provides a comprehensive analysis of the global FIB-SEM System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIB-SEM System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global FIB-SEM System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIB-SEM System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIB-SEM System.
This report presents a comprehensive overview, market shares, and growth opportunities of FIB-SEM System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Ga Ion Source
- Non-Ga Ion Source
- Material Science
- Life Sciences
- Semiconductor
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Hitachi
- Zeiss
- JEOL Ltd
- Tescan Group
- Raith
What is the 10-year outlook for the global FIB-SEM System market?
What factors are driving FIB-SEM System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIB-SEM System market opportunities vary by end market size?
How does FIB-SEM System break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Blood Vessel Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artificial Blood Vessel by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artificial Blood Vessel by Country/Region, 2020, 2024 & 2031
2.2 Artificial Blood Vessel Segment by Type
2.2.1 EPTFE
2.2.2 Polyethylene Terephthalate
2.2.3 Polyurethane
2.2.4 Others
2.3 Artificial Blood Vessel Sales by Type
2.3.1 Global Artificial Blood Vessel Sales Market Share by Type (2020-2025)
2.3.2 Global Artificial Blood Vessel Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artificial Blood Vessel Sale Price by Type (2020-2025)
2.4 Artificial Blood Vessel Segment by Application
2.4.1 Aortic Disease
2.4.2 Peripheral Artery Disease
2.4.3 Hemodialysis
2.5 Artificial Blood Vessel Sales by Application
2.5.1 Global Artificial Blood Vessel Sale Market Share by Application (2020-2025)
2.5.2 Global Artificial Blood Vessel Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artificial Blood Vessel Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artificial Blood Vessel Breakdown Data by Company
3.1.1 Global Artificial Blood Vessel Annual Sales by Company (2020-2025)
3.1.2 Global Artificial Blood Vessel Sales Market Share by Company (2020-2025)
3.2 Global Artificial Blood Vessel Annual Revenue by Company (2020-2025)
3.2.1 Global Artificial Blood Vessel Revenue by Company (2020-2025)
3.2.2 Global Artificial Blood Vessel Revenue Market Share by Company (2020-2025)
3.3 Global Artificial Blood Vessel Sale Price by Company
3.4 Key Manufacturers Artificial Blood Vessel Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Blood Vessel Product Location Distribution
3.4.2 Players Artificial Blood Vessel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL BLOOD VESSEL BY GEOGRAPHIC REGION
4.1 World Historic Artificial Blood Vessel Market Size by Geographic Region (2020-2025)
4.1.1 Global Artificial Blood Vessel Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artificial Blood Vessel Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artificial Blood Vessel Market Size by Country/Region (2020-2025)
4.2.1 Global Artificial Blood Vessel Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artificial Blood Vessel Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artificial Blood Vessel Sales Growth
4.4 APAC Artificial Blood Vessel Sales Growth
4.5 Europe Artificial Blood Vessel Sales Growth
4.6 Middle East & Africa Artificial Blood Vessel Sales Growth
5 AMERICAS
5.1 Americas Artificial Blood Vessel Sales by Country
5.1.1 Americas Artificial Blood Vessel Sales by Country (2020-2025)
5.1.2 Americas Artificial Blood Vessel Revenue by Country (2020-2025)
5.2 Americas Artificial Blood Vessel Sales by Type (2020-2025)
5.3 Americas Artificial Blood Vessel Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Blood Vessel Sales by Region
6.1.1 APAC Artificial Blood Vessel Sales by Region (2020-2025)
6.1.2 APAC Artificial Blood Vessel Revenue by Region (2020-2025)
6.2 APAC Artificial Blood Vessel Sales by Type (2020-2025)
6.3 APAC Artificial Blood Vessel Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Blood Vessel by Country
7.1.1 Europe Artificial Blood Vessel Sales by Country (2020-2025)
7.1.2 Europe Artificial Blood Vessel Revenue by Country (2020-2025)
7.2 Europe Artificial Blood Vessel Sales by Type (2020-2025)
7.3 Europe Artificial Blood Vessel Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Blood Vessel by Country
8.1.1 Middle East & Africa Artificial Blood Vessel Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artificial Blood Vessel Revenue by Country (2020-2025)
8.2 Middle East & Africa Artificial Blood Vessel Sales by Type (2020-2025)
8.3 Middle East & Africa Artificial Blood Vessel Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Blood Vessel
10.3 Manufacturing Process Analysis of Artificial Blood Vessel
10.4 Industry Chain Structure of Artificial Blood Vessel
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Blood Vessel Distributors
11.3 Artificial Blood Vessel Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL BLOOD VESSEL BY GEOGRAPHIC REGION
12.1 Global Artificial Blood Vessel Market Size Forecast by Region
12.1.1 Global Artificial Blood Vessel Forecast by Region (2026-2031)
12.1.2 Global Artificial Blood Vessel Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artificial Blood Vessel Forecast by Type (2026-2031)
12.7 Global Artificial Blood Vessel Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Getinge
13.1.1 Getinge Company Information
13.1.2 Getinge Artificial Blood Vessel Product Portfolios and Specifications
13.1.3 Getinge Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Getinge Main Business Overview
13.1.5 Getinge Latest Developments
13.2 Bard PV
13.2.1 Bard PV Company Information
13.2.2 Bard PV Artificial Blood Vessel Product Portfolios and Specifications
13.2.3 Bard PV Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bard PV Main Business Overview
13.2.5 Bard PV Latest Developments
13.3 Terumo
13.3.1 Terumo Company Information
13.3.2 Terumo Artificial Blood Vessel Product Portfolios and Specifications
13.3.3 Terumo Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Terumo Main Business Overview
13.3.5 Terumo Latest Developments
13.4 W. L. Gore
13.4.1 W. L. Gore Company Information
13.4.2 W. L. Gore Artificial Blood Vessel Product Portfolios and Specifications
13.4.3 W. L. Gore Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 W. L. Gore Main Business Overview
13.4.5 W. L. Gore Latest Developments
13.5 Japan Lifeline
13.5.1 Japan Lifeline Company Information
13.5.2 Japan Lifeline Artificial Blood Vessel Product Portfolios and Specifications
13.5.3 Japan Lifeline Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Japan Lifeline Main Business Overview
13.5.5 Japan Lifeline Latest Developments
13.6 B.Braun
13.6.1 B.Braun Company Information
13.6.2 B.Braun Artificial Blood Vessel Product Portfolios and Specifications
13.6.3 B.Braun Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 B.Braun Main Business Overview
13.6.5 B.Braun Latest Developments
13.7 LeMaitre Vascular
13.7.1 LeMaitre Vascular Company Information
13.7.2 LeMaitre Vascular Artificial Blood Vessel Product Portfolios and Specifications
13.7.3 LeMaitre Vascular Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 LeMaitre Vascular Main Business Overview
13.7.5 LeMaitre Vascular Latest Developments
13.8 Shanghai Chest Medical Instruments
13.8.1 Shanghai Chest Medical Instruments Company Information
13.8.2 Shanghai Chest Medical Instruments Artificial Blood Vessel Product Portfolios and Specifications
13.8.3 Shanghai Chest Medical Instruments Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shanghai Chest Medical Instruments Main Business Overview
13.8.5 Shanghai Chest Medical Instruments Latest Developments
13.9 Aortec Medical Technology
13.9.1 Aortec Medical Technology Company Information
13.9.2 Aortec Medical Technology Artificial Blood Vessel Product Portfolios and Specifications
13.9.3 Aortec Medical Technology Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aortec Medical Technology Main Business Overview
13.9.5 Aortec Medical Technology Latest Developments
13.10 JIANGSU BIODA LIFE SCIENCE
13.10.1 JIANGSU BIODA LIFE SCIENCE Company Information
13.10.2 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Product Portfolios and Specifications
13.10.3 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 JIANGSU BIODA LIFE SCIENCE Main Business Overview
13.10.5 JIANGSU BIODA LIFE SCIENCE Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Blood Vessel Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artificial Blood Vessel by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artificial Blood Vessel by Country/Region, 2020, 2024 & 2031
2.2 Artificial Blood Vessel Segment by Type
2.2.1 EPTFE
2.2.2 Polyethylene Terephthalate
2.2.3 Polyurethane
2.2.4 Others
2.3 Artificial Blood Vessel Sales by Type
2.3.1 Global Artificial Blood Vessel Sales Market Share by Type (2020-2025)
2.3.2 Global Artificial Blood Vessel Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artificial Blood Vessel Sale Price by Type (2020-2025)
2.4 Artificial Blood Vessel Segment by Application
2.4.1 Aortic Disease
2.4.2 Peripheral Artery Disease
2.4.3 Hemodialysis
2.5 Artificial Blood Vessel Sales by Application
2.5.1 Global Artificial Blood Vessel Sale Market Share by Application (2020-2025)
2.5.2 Global Artificial Blood Vessel Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artificial Blood Vessel Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artificial Blood Vessel Breakdown Data by Company
3.1.1 Global Artificial Blood Vessel Annual Sales by Company (2020-2025)
3.1.2 Global Artificial Blood Vessel Sales Market Share by Company (2020-2025)
3.2 Global Artificial Blood Vessel Annual Revenue by Company (2020-2025)
3.2.1 Global Artificial Blood Vessel Revenue by Company (2020-2025)
3.2.2 Global Artificial Blood Vessel Revenue Market Share by Company (2020-2025)
3.3 Global Artificial Blood Vessel Sale Price by Company
3.4 Key Manufacturers Artificial Blood Vessel Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Blood Vessel Product Location Distribution
3.4.2 Players Artificial Blood Vessel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL BLOOD VESSEL BY GEOGRAPHIC REGION
4.1 World Historic Artificial Blood Vessel Market Size by Geographic Region (2020-2025)
4.1.1 Global Artificial Blood Vessel Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artificial Blood Vessel Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artificial Blood Vessel Market Size by Country/Region (2020-2025)
4.2.1 Global Artificial Blood Vessel Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artificial Blood Vessel Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artificial Blood Vessel Sales Growth
4.4 APAC Artificial Blood Vessel Sales Growth
4.5 Europe Artificial Blood Vessel Sales Growth
4.6 Middle East & Africa Artificial Blood Vessel Sales Growth
5 AMERICAS
5.1 Americas Artificial Blood Vessel Sales by Country
5.1.1 Americas Artificial Blood Vessel Sales by Country (2020-2025)
5.1.2 Americas Artificial Blood Vessel Revenue by Country (2020-2025)
5.2 Americas Artificial Blood Vessel Sales by Type (2020-2025)
5.3 Americas Artificial Blood Vessel Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Blood Vessel Sales by Region
6.1.1 APAC Artificial Blood Vessel Sales by Region (2020-2025)
6.1.2 APAC Artificial Blood Vessel Revenue by Region (2020-2025)
6.2 APAC Artificial Blood Vessel Sales by Type (2020-2025)
6.3 APAC Artificial Blood Vessel Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Blood Vessel by Country
7.1.1 Europe Artificial Blood Vessel Sales by Country (2020-2025)
7.1.2 Europe Artificial Blood Vessel Revenue by Country (2020-2025)
7.2 Europe Artificial Blood Vessel Sales by Type (2020-2025)
7.3 Europe Artificial Blood Vessel Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Blood Vessel by Country
8.1.1 Middle East & Africa Artificial Blood Vessel Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artificial Blood Vessel Revenue by Country (2020-2025)
8.2 Middle East & Africa Artificial Blood Vessel Sales by Type (2020-2025)
8.3 Middle East & Africa Artificial Blood Vessel Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Blood Vessel
10.3 Manufacturing Process Analysis of Artificial Blood Vessel
10.4 Industry Chain Structure of Artificial Blood Vessel
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Blood Vessel Distributors
11.3 Artificial Blood Vessel Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL BLOOD VESSEL BY GEOGRAPHIC REGION
12.1 Global Artificial Blood Vessel Market Size Forecast by Region
12.1.1 Global Artificial Blood Vessel Forecast by Region (2026-2031)
12.1.2 Global Artificial Blood Vessel Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artificial Blood Vessel Forecast by Type (2026-2031)
12.7 Global Artificial Blood Vessel Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Getinge
13.1.1 Getinge Company Information
13.1.2 Getinge Artificial Blood Vessel Product Portfolios and Specifications
13.1.3 Getinge Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Getinge Main Business Overview
13.1.5 Getinge Latest Developments
13.2 Bard PV
13.2.1 Bard PV Company Information
13.2.2 Bard PV Artificial Blood Vessel Product Portfolios and Specifications
13.2.3 Bard PV Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bard PV Main Business Overview
13.2.5 Bard PV Latest Developments
13.3 Terumo
13.3.1 Terumo Company Information
13.3.2 Terumo Artificial Blood Vessel Product Portfolios and Specifications
13.3.3 Terumo Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Terumo Main Business Overview
13.3.5 Terumo Latest Developments
13.4 W. L. Gore
13.4.1 W. L. Gore Company Information
13.4.2 W. L. Gore Artificial Blood Vessel Product Portfolios and Specifications
13.4.3 W. L. Gore Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 W. L. Gore Main Business Overview
13.4.5 W. L. Gore Latest Developments
13.5 Japan Lifeline
13.5.1 Japan Lifeline Company Information
13.5.2 Japan Lifeline Artificial Blood Vessel Product Portfolios and Specifications
13.5.3 Japan Lifeline Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Japan Lifeline Main Business Overview
13.5.5 Japan Lifeline Latest Developments
13.6 B.Braun
13.6.1 B.Braun Company Information
13.6.2 B.Braun Artificial Blood Vessel Product Portfolios and Specifications
13.6.3 B.Braun Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 B.Braun Main Business Overview
13.6.5 B.Braun Latest Developments
13.7 LeMaitre Vascular
13.7.1 LeMaitre Vascular Company Information
13.7.2 LeMaitre Vascular Artificial Blood Vessel Product Portfolios and Specifications
13.7.3 LeMaitre Vascular Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 LeMaitre Vascular Main Business Overview
13.7.5 LeMaitre Vascular Latest Developments
13.8 Shanghai Chest Medical Instruments
13.8.1 Shanghai Chest Medical Instruments Company Information
13.8.2 Shanghai Chest Medical Instruments Artificial Blood Vessel Product Portfolios and Specifications
13.8.3 Shanghai Chest Medical Instruments Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shanghai Chest Medical Instruments Main Business Overview
13.8.5 Shanghai Chest Medical Instruments Latest Developments
13.9 Aortec Medical Technology
13.9.1 Aortec Medical Technology Company Information
13.9.2 Aortec Medical Technology Artificial Blood Vessel Product Portfolios and Specifications
13.9.3 Aortec Medical Technology Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aortec Medical Technology Main Business Overview
13.9.5 Aortec Medical Technology Latest Developments
13.10 JIANGSU BIODA LIFE SCIENCE
13.10.1 JIANGSU BIODA LIFE SCIENCE Company Information
13.10.2 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Product Portfolios and Specifications
13.10.3 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 JIANGSU BIODA LIFE SCIENCE Main Business Overview
13.10.5 JIANGSU BIODA LIFE SCIENCE Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Blood Vessel Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artificial Blood Vessel Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of EPTFE
Table 4. Major Players of Polyethylene Terephthalate
Table 5. Major Players of Polyurethane
Table 6. Major Players of Others
Table 7. Global Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 8. Global Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Table 9. Global Artificial Blood Vessel Revenue by Type (2020-2025) & ($ million)
Table 10. Global Artificial Blood Vessel Revenue Market Share by Type (2020-2025)
Table 11. Global Artificial Blood Vessel Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Artificial Blood Vessel Sale by Application (2020-2025) & (K Units)
Table 13. Global Artificial Blood Vessel Sale Market Share by Application (2020-2025)
Table 14. Global Artificial Blood Vessel Revenue by Application (2020-2025) & ($ million)
Table 15. Global Artificial Blood Vessel Revenue Market Share by Application (2020-2025)
Table 16. Global Artificial Blood Vessel Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Artificial Blood Vessel Sales by Company (2020-2025) & (K Units)
Table 18. Global Artificial Blood Vessel Sales Market Share by Company (2020-2025)
Table 19. Global Artificial Blood Vessel Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Artificial Blood Vessel Revenue Market Share by Company (2020-2025)
Table 21. Global Artificial Blood Vessel Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Artificial Blood Vessel Producing Area Distribution and Sales Area
Table 23. Players Artificial Blood Vessel Products Offered
Table 24. Artificial Blood Vessel Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Artificial Blood Vessel Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Artificial Blood Vessel Sales Market Share Geographic Region (2020-2025)
Table 29. Global Artificial Blood Vessel Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Artificial Blood Vessel Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Artificial Blood Vessel Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Artificial Blood Vessel Sales Market Share by Country/Region (2020-2025)
Table 33. Global Artificial Blood Vessel Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Artificial Blood Vessel Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Artificial Blood Vessel Sales by Country (2020-2025) & (K Units)
Table 36. Americas Artificial Blood Vessel Sales Market Share by Country (2020-2025)
Table 37. Americas Artificial Blood Vessel Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 39. Americas Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 40. APAC Artificial Blood Vessel Sales by Region (2020-2025) & (K Units)
Table 41. APAC Artificial Blood Vessel Sales Market Share by Region (2020-2025)
Table 42. APAC Artificial Blood Vessel Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 44. APAC Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 45. Europe Artificial Blood Vessel Sales by Country (2020-2025) & (K Units)
Table 46. Europe Artificial Blood Vessel Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 48. Europe Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Artificial Blood Vessel Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Artificial Blood Vessel Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Artificial Blood Vessel
Table 54. Key Market Challenges & Risks of Artificial Blood Vessel
Table 55. Key Industry Trends of Artificial Blood Vessel
Table 56. Artificial Blood Vessel Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Artificial Blood Vessel Distributors List
Table 59. Artificial Blood Vessel Customer List
Table 60. Global Artificial Blood Vessel Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Artificial Blood Vessel Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Artificial Blood Vessel Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Artificial Blood Vessel Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Artificial Blood Vessel Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Artificial Blood Vessel Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Artificial Blood Vessel Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Artificial Blood Vessel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Artificial Blood Vessel Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Artificial Blood Vessel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Artificial Blood Vessel Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Artificial Blood Vessel Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Artificial Blood Vessel Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Artificial Blood Vessel Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Getinge Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 75. Getinge Artificial Blood Vessel Product Portfolios and Specifications
Table 76. Getinge Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Getinge Main Business
Table 78. Getinge Latest Developments
Table 79. Bard PV Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 80. Bard PV Artificial Blood Vessel Product Portfolios and Specifications
Table 81. Bard PV Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bard PV Main Business
Table 83. Bard PV Latest Developments
Table 84. Terumo Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 85. Terumo Artificial Blood Vessel Product Portfolios and Specifications
Table 86. Terumo Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Terumo Main Business
Table 88. Terumo Latest Developments
Table 89. W. L. Gore Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 90. W. L. Gore Artificial Blood Vessel Product Portfolios and Specifications
Table 91. W. L. Gore Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. W. L. Gore Main Business
Table 93. W. L. Gore Latest Developments
Table 94. Japan Lifeline Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 95. Japan Lifeline Artificial Blood Vessel Product Portfolios and Specifications
Table 96. Japan Lifeline Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Japan Lifeline Main Business
Table 98. Japan Lifeline Latest Developments
Table 99. B.Braun Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 100. B.Braun Artificial Blood Vessel Product Portfolios and Specifications
Table 101. B.Braun Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. B.Braun Main Business
Table 103. B.Braun Latest Developments
Table 104. LeMaitre Vascular Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 105. LeMaitre Vascular Artificial Blood Vessel Product Portfolios and Specifications
Table 106. LeMaitre Vascular Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. LeMaitre Vascular Main Business
Table 108. LeMaitre Vascular Latest Developments
Table 109. Shanghai Chest Medical Instruments Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 110. Shanghai Chest Medical Instruments Artificial Blood Vessel Product Portfolios and Specifications
Table 111. Shanghai Chest Medical Instruments Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Shanghai Chest Medical Instruments Main Business
Table 113. Shanghai Chest Medical Instruments Latest Developments
Table 114. Aortec Medical Technology Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 115. Aortec Medical Technology Artificial Blood Vessel Product Portfolios and Specifications
Table 116. Aortec Medical Technology Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Aortec Medical Technology Main Business
Table 118. Aortec Medical Technology Latest Developments
Table 119. JIANGSU BIODA LIFE SCIENCE Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 120. JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Product Portfolios and Specifications
Table 121. JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. JIANGSU BIODA LIFE SCIENCE Main Business
Table 123. JIANGSU BIODA LIFE SCIENCE Latest Developments
Table 1. Artificial Blood Vessel Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artificial Blood Vessel Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of EPTFE
Table 4. Major Players of Polyethylene Terephthalate
Table 5. Major Players of Polyurethane
Table 6. Major Players of Others
Table 7. Global Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 8. Global Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Table 9. Global Artificial Blood Vessel Revenue by Type (2020-2025) & ($ million)
Table 10. Global Artificial Blood Vessel Revenue Market Share by Type (2020-2025)
Table 11. Global Artificial Blood Vessel Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Artificial Blood Vessel Sale by Application (2020-2025) & (K Units)
Table 13. Global Artificial Blood Vessel Sale Market Share by Application (2020-2025)
Table 14. Global Artificial Blood Vessel Revenue by Application (2020-2025) & ($ million)
Table 15. Global Artificial Blood Vessel Revenue Market Share by Application (2020-2025)
Table 16. Global Artificial Blood Vessel Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Artificial Blood Vessel Sales by Company (2020-2025) & (K Units)
Table 18. Global Artificial Blood Vessel Sales Market Share by Company (2020-2025)
Table 19. Global Artificial Blood Vessel Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Artificial Blood Vessel Revenue Market Share by Company (2020-2025)
Table 21. Global Artificial Blood Vessel Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Artificial Blood Vessel Producing Area Distribution and Sales Area
Table 23. Players Artificial Blood Vessel Products Offered
Table 24. Artificial Blood Vessel Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Artificial Blood Vessel Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Artificial Blood Vessel Sales Market Share Geographic Region (2020-2025)
Table 29. Global Artificial Blood Vessel Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Artificial Blood Vessel Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Artificial Blood Vessel Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Artificial Blood Vessel Sales Market Share by Country/Region (2020-2025)
Table 33. Global Artificial Blood Vessel Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Artificial Blood Vessel Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Artificial Blood Vessel Sales by Country (2020-2025) & (K Units)
Table 36. Americas Artificial Blood Vessel Sales Market Share by Country (2020-2025)
Table 37. Americas Artificial Blood Vessel Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 39. Americas Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 40. APAC Artificial Blood Vessel Sales by Region (2020-2025) & (K Units)
Table 41. APAC Artificial Blood Vessel Sales Market Share by Region (2020-2025)
Table 42. APAC Artificial Blood Vessel Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 44. APAC Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 45. Europe Artificial Blood Vessel Sales by Country (2020-2025) & (K Units)
Table 46. Europe Artificial Blood Vessel Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 48. Europe Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Artificial Blood Vessel Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Artificial Blood Vessel Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Artificial Blood Vessel Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Artificial Blood Vessel Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Artificial Blood Vessel
Table 54. Key Market Challenges & Risks of Artificial Blood Vessel
Table 55. Key Industry Trends of Artificial Blood Vessel
Table 56. Artificial Blood Vessel Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Artificial Blood Vessel Distributors List
Table 59. Artificial Blood Vessel Customer List
Table 60. Global Artificial Blood Vessel Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Artificial Blood Vessel Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Artificial Blood Vessel Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Artificial Blood Vessel Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Artificial Blood Vessel Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Artificial Blood Vessel Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Artificial Blood Vessel Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Artificial Blood Vessel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Artificial Blood Vessel Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Artificial Blood Vessel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Artificial Blood Vessel Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Artificial Blood Vessel Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Artificial Blood Vessel Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Artificial Blood Vessel Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Getinge Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 75. Getinge Artificial Blood Vessel Product Portfolios and Specifications
Table 76. Getinge Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Getinge Main Business
Table 78. Getinge Latest Developments
Table 79. Bard PV Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 80. Bard PV Artificial Blood Vessel Product Portfolios and Specifications
Table 81. Bard PV Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bard PV Main Business
Table 83. Bard PV Latest Developments
Table 84. Terumo Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 85. Terumo Artificial Blood Vessel Product Portfolios and Specifications
Table 86. Terumo Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Terumo Main Business
Table 88. Terumo Latest Developments
Table 89. W. L. Gore Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 90. W. L. Gore Artificial Blood Vessel Product Portfolios and Specifications
Table 91. W. L. Gore Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. W. L. Gore Main Business
Table 93. W. L. Gore Latest Developments
Table 94. Japan Lifeline Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 95. Japan Lifeline Artificial Blood Vessel Product Portfolios and Specifications
Table 96. Japan Lifeline Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Japan Lifeline Main Business
Table 98. Japan Lifeline Latest Developments
Table 99. B.Braun Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 100. B.Braun Artificial Blood Vessel Product Portfolios and Specifications
Table 101. B.Braun Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. B.Braun Main Business
Table 103. B.Braun Latest Developments
Table 104. LeMaitre Vascular Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 105. LeMaitre Vascular Artificial Blood Vessel Product Portfolios and Specifications
Table 106. LeMaitre Vascular Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. LeMaitre Vascular Main Business
Table 108. LeMaitre Vascular Latest Developments
Table 109. Shanghai Chest Medical Instruments Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 110. Shanghai Chest Medical Instruments Artificial Blood Vessel Product Portfolios and Specifications
Table 111. Shanghai Chest Medical Instruments Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Shanghai Chest Medical Instruments Main Business
Table 113. Shanghai Chest Medical Instruments Latest Developments
Table 114. Aortec Medical Technology Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 115. Aortec Medical Technology Artificial Blood Vessel Product Portfolios and Specifications
Table 116. Aortec Medical Technology Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Aortec Medical Technology Main Business
Table 118. Aortec Medical Technology Latest Developments
Table 119. JIANGSU BIODA LIFE SCIENCE Basic Information, Artificial Blood Vessel Manufacturing Base, Sales Area and Its Competitors
Table 120. JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Product Portfolios and Specifications
Table 121. JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. JIANGSU BIODA LIFE SCIENCE Main Business
Table 123. JIANGSU BIODA LIFE SCIENCE Latest Developments
LIST OF FIGURES
Figure 1. Picture of Artificial Blood Vessel
Figure 2. Artificial Blood Vessel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Blood Vessel Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Artificial Blood Vessel Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artificial Blood Vessel Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artificial Blood Vessel Sales Market Share by Country/Region (2024)
Figure 10. Artificial Blood Vessel Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of EPTFE
Figure 12. Product Picture of Polyethylene Terephthalate
Figure 13. Product Picture of Polyurethane
Figure 14. Product Picture of Others
Figure 15. Global Artificial Blood Vessel Sales Market Share by Type in 2025
Figure 16. Global Artificial Blood Vessel Revenue Market Share by Type (2020-2025)
Figure 17. Artificial Blood Vessel Consumed in Aortic Disease
Figure 18. Global Artificial Blood Vessel Market: Aortic Disease (2020-2025) & (K Units)
Figure 19. Artificial Blood Vessel Consumed in Peripheral Artery Disease
Figure 20. Global Artificial Blood Vessel Market: Peripheral Artery Disease (2020-2025) & (K Units)
Figure 21. Artificial Blood Vessel Consumed in Hemodialysis
Figure 22. Global Artificial Blood Vessel Market: Hemodialysis (2020-2025) & (K Units)
Figure 23. Global Artificial Blood Vessel Sale Market Share by Application (2024)
Figure 24. Global Artificial Blood Vessel Revenue Market Share by Application in 2025
Figure 25. Artificial Blood Vessel Sales by Company in 2025 (K Units)
Figure 26. Global Artificial Blood Vessel Sales Market Share by Company in 2025
Figure 27. Artificial Blood Vessel Revenue by Company in 2025 ($ millions)
Figure 28. Global Artificial Blood Vessel Revenue Market Share by Company in 2025
Figure 29. Global Artificial Blood Vessel Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Artificial Blood Vessel Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 32. Americas Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 33. APAC Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 34. APAC Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 35. Europe Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 36. Europe Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 39. Americas Artificial Blood Vessel Sales Market Share by Country in 2025
Figure 40. Americas Artificial Blood Vessel Revenue Market Share by Country (2020-2025)
Figure 41. Americas Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 42. Americas Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 43. United States Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Artificial Blood Vessel Sales Market Share by Region in 2025
Figure 48. APAC Artificial Blood Vessel Revenue Market Share by Region (2020-2025)
Figure 49. APAC Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 50. APAC Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 51. China Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 55. India Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Artificial Blood Vessel Sales Market Share by Country in 2025
Figure 59. Europe Artificial Blood Vessel Revenue Market Share by Country (2020-2025)
Figure 60. Europe Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 61. Europe Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 62. Germany Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 63. France Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Artificial Blood Vessel Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 70. Egypt Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Artificial Blood Vessel in 2025
Figure 76. Manufacturing Process Analysis of Artificial Blood Vessel
Figure 77. Industry Chain Structure of Artificial Blood Vessel
Figure 78. Channels of Distribution
Figure 79. Global Artificial Blood Vessel Sales Market Forecast by Region (2026-2031)
Figure 80. Global Artificial Blood Vessel Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Artificial Blood Vessel Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Artificial Blood Vessel Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Artificial Blood Vessel Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Artificial Blood Vessel Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Artificial Blood Vessel
Figure 2. Artificial Blood Vessel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Blood Vessel Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Artificial Blood Vessel Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artificial Blood Vessel Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artificial Blood Vessel Sales Market Share by Country/Region (2024)
Figure 10. Artificial Blood Vessel Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of EPTFE
Figure 12. Product Picture of Polyethylene Terephthalate
Figure 13. Product Picture of Polyurethane
Figure 14. Product Picture of Others
Figure 15. Global Artificial Blood Vessel Sales Market Share by Type in 2025
Figure 16. Global Artificial Blood Vessel Revenue Market Share by Type (2020-2025)
Figure 17. Artificial Blood Vessel Consumed in Aortic Disease
Figure 18. Global Artificial Blood Vessel Market: Aortic Disease (2020-2025) & (K Units)
Figure 19. Artificial Blood Vessel Consumed in Peripheral Artery Disease
Figure 20. Global Artificial Blood Vessel Market: Peripheral Artery Disease (2020-2025) & (K Units)
Figure 21. Artificial Blood Vessel Consumed in Hemodialysis
Figure 22. Global Artificial Blood Vessel Market: Hemodialysis (2020-2025) & (K Units)
Figure 23. Global Artificial Blood Vessel Sale Market Share by Application (2024)
Figure 24. Global Artificial Blood Vessel Revenue Market Share by Application in 2025
Figure 25. Artificial Blood Vessel Sales by Company in 2025 (K Units)
Figure 26. Global Artificial Blood Vessel Sales Market Share by Company in 2025
Figure 27. Artificial Blood Vessel Revenue by Company in 2025 ($ millions)
Figure 28. Global Artificial Blood Vessel Revenue Market Share by Company in 2025
Figure 29. Global Artificial Blood Vessel Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Artificial Blood Vessel Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 32. Americas Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 33. APAC Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 34. APAC Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 35. Europe Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 36. Europe Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Artificial Blood Vessel Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Artificial Blood Vessel Revenue 2020-2025 ($ millions)
Figure 39. Americas Artificial Blood Vessel Sales Market Share by Country in 2025
Figure 40. Americas Artificial Blood Vessel Revenue Market Share by Country (2020-2025)
Figure 41. Americas Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 42. Americas Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 43. United States Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Artificial Blood Vessel Sales Market Share by Region in 2025
Figure 48. APAC Artificial Blood Vessel Revenue Market Share by Region (2020-2025)
Figure 49. APAC Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 50. APAC Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 51. China Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 55. India Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Artificial Blood Vessel Sales Market Share by Country in 2025
Figure 59. Europe Artificial Blood Vessel Revenue Market Share by Country (2020-2025)
Figure 60. Europe Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 61. Europe Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 62. Germany Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 63. France Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Artificial Blood Vessel Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Artificial Blood Vessel Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Artificial Blood Vessel Sales Market Share by Application (2020-2025)
Figure 70. Egypt Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Artificial Blood Vessel Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Artificial Blood Vessel in 2025
Figure 76. Manufacturing Process Analysis of Artificial Blood Vessel
Figure 77. Industry Chain Structure of Artificial Blood Vessel
Figure 78. Channels of Distribution
Figure 79. Global Artificial Blood Vessel Sales Market Forecast by Region (2026-2031)
Figure 80. Global Artificial Blood Vessel Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Artificial Blood Vessel Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Artificial Blood Vessel Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Artificial Blood Vessel Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Artificial Blood Vessel Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Compressor Nebulizer System Market Growth 2024-2030
US$ 3,660.00
February 2024
111 pages
Global Acute Repetitive Seizures Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
90 pages
